Matthijs J. D. Baars

Matthijs J. D. Baars

Auto-generated profile, based on publicly available information

Matthijs J. D. Baars

Oncode Institute, Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center Utrecht, Utrecht, the Netherlands

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2022 in Cancers
Verified
Journal Article
Open access
PDF file
SDStephanie van Dam
Stephanie van Dam
MBMatthijs J. D. Baars
Matthijs J. D. Baars
YVYvonne Vercoulen
Yvonne Vercoulen
The tumor microenvironment is a complex ecosystem containing various cell types, such as immune cells, fibroblasts, and endothelial cells, which interact with the tumor cells. In recent decades, the cancer research field has gained insight into the cellular subtypes that are involved in tumor microenvironment heterogeneity. Moreover, it has become evident that cellular interactions in the tumor microenvironment can either promote or inhibit tumor development, progression, and drug resistance, depending on the context. Multiplex spatial analysis methods have recently been developed; these have offered insight into how cellular crosstalk dynamics and heterogeneity affect cancer prognoses and responses to treatment. Multiplex (imaging) technologies and computational analysis methods allow for the spatial visualization and quantification of cell–cell interactions and properties. These technological advances allow for the discovery of cellular interactions within the tumor microenvironment and provide detailed single-cell information on properties that define cellular behavior. Such analyses give insights into the prognosis and mechanisms of therapy resistance, which is still an urgent problem in the treatment of multiple types of cancer. Here, we provide an overview of multiplex imaging technologies and concepts of downstream analysis methods to investigate cell–cell interactions, how these studies have advanced cancer research, and their potential clinical implications.

1 October 2021 in JHEP Reports
Verified
Journal Article
Open access
NINoortje Ijssennagger
Noortje Ijssennagger
KRKristel S. van Rooijen
Kristel S. van Rooijen
SMStefanía Magnúsdóttir
Stefanía Magnúsdóttir
JPJosé M. Ramos Pittol
José M. Ramos Pittol
EWEllen C.L. Willemsen
Ellen C.L. Willemsen
SMSaskia W.C. van Mil
Saskia W.C. van Mil
The interorgan crosstalk between the liver and the intestine has been the focus of intense research. Key in this crosstalk are bile acids, which are secreted from the liver into the intestine, interact with the microbiome, and upon absorption reach back to the liver. The bile acid-activated farnesoid X receptor (Fxr) is involved in the gut-to-liver axis. However, liver-to-gut communication and the roles of bile acids and Fxr remain elusive. Herein, we aim to get a better understanding of Fxr-mediated liver-to-gut communication, particularly in colon functioning. Fxr floxed/floxed mice were crossed with cre-expressing mice to yield Fxr ablation in the intestine (Fxr-intKO), liver (Fxr-livKO), or total body (Fxr-totKO). The effects on colonic gene expression (RNA sequencing), the microbiome (16S sequencing), and mucus barrier function by ex vivo imaging were analysed. Despite relatively small changes in biliary bile acid concentration and composition, more genes were differentially expressed in the colons of Fxr-livKO mice than in those of Fxr-intKO and Fxr-totKO mice (3272, 731, and 1824, respectively). The colons of Fxr-livKO showed increased expression of antimicrobial genes, Toll-like receptors, inflammasome-related genes and genes belonging to the 'Mucin-type O-glycan biosynthesis' pathway. Fxr-livKO mice have a microbiome profile favourable for the protective capacity of the mucus barrier. The thickness of the inner sterile mucus layer was increased and colitis symptoms reduced in Fxr-livKO mice. Targeting of FXR is at the forefront in the battle against metabolic diseases. We show that ablation of Fxr in the liver greatly impacts colonic gene expression and increased the colonic mucus barrier. Increasing the mucus barrier is of utmost importance to battle intestinal diseases such as inflammatory bowel disease, and we show that this might be done by antagonising FXR in the liver. This study shows that the communication of the liver to the intestine is crucial for intestinal health. Bile acids are key players in this liver-to-gut communication, and when Fxr, the master regulator of bile acid homoeostasis, is ablated in the liver, colonic gene expression is largely affected, and the protective capacity of the mucus barrier is increased.

15 December 2021 in STAR Protocols
Verified
Journal Article
Open access
Daniëlle KrijgsmanDaniëlle Krijgsman
Daniëlle Krijgsman
NSNeeraj Sinha
Neeraj Sinha
MBMatthijs J.D. Baars
Matthijs J.D. Baars
SDStephanie van Dam
Stephanie van Dam
MAMojtaba Amini
Mojtaba Amini
YVYvonne Vercoulen
Yvonne Vercoulen
Exploring tissue heterogeneity on a single-cell level by imaging mass cytometry (IMC) remains challenging because of its limiting resolution. We previously demonstrated that combining higher resolution fluorescence with IMC data in the analysis pipeline resulted in high-quality single-cell segmentation. Here, we provide a step-by-step workflow of this MATISSE pipeline, including instructions regarding the staining procedure, and the analysis route to generate single-cell data.

2 December 2023 in British Journal of Cancer
Verified
Journal Article
Closed access
PDF file
EKEmre Küçükköse
Emre Küçükköse
MBMatthijs J. D. Baars
Matthijs J. D. Baars
MAMojtaba Amini
Mojtaba Amini
SSSuzanna J. Schraa
Suzanna J. Schraa
EFEvelien Floor
Evelien Floor
YVYvonne Vercoulen
Yvonne Vercoulen

28 January 2026 in Nature
Verified
Journal Article
Open access
PDF file
DRDhanushika Ratnayake
Dhanushika Ratnayake
MGMarie Galloux
Marie Galloux
SBSanne Boersma
Sanne Boersma
Marko NoerenbergMarko Noerenberg
Marko Noerenberg
CSChristina Sizun
Christina Sizun
MTMarvin E. Tanenbaum
Marvin E. Tanenbaum
During infection, many RNA viruses, including respiratory syncytial virus (RSV), form specialized biomolecular condensates, viral factories (VFs), where viral transcription and replication occur1,2. Paradoxically, high protein concentrations are typically required for condensate nucleation3, yet attaining sufficient protein levels in infection is thought to require VFs for viral transcription and replication. Here, to uncover how viruses solve this paradox to establish VFs, we visualized early infection of RSV in real time with single genomic viral ribonucleoprotein (vRNP) resolution. Our results reveal that VFs are nucleated from infecting vRNPs rather than de novo in the cytoplasm. VF nucleation further requires in-virion pre-assembly of viral protein–protein interaction networks on vRNPs to form ‘pre-replication centres’ (PRCs). PRCs are potent condensate nucleation seeds due to their efficient recruitment and retention of viral proteins. The high affinity of PRCs also results in increased association of the viral polymerase and its co-factors, allowing efficient viral transcription even in the absence of VFs. Together, these activities create a feed-forward loop that drives rapid VF formation. PRC assembly depends on in-virion viral protein levels and is highly heterogeneous among virions, explaining cell-to-cell heterogeneity in infection progression, and identifying heterogeneous virions as an important origin of infection heterogeneity. Together, our results show that in-virion pre-assembly of PRCs kick-starts viral condensate nucleation upon host-cell entry and explains cell-to-cell heterogeneity in RSV infection.

20 January 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
HRHuib H. Rabouw
Huib H. Rabouw
JSJanin Schokolowski
Janin Schokolowski
MMMicha Müller
Micha Müller
MBMatthijs J.D. Baars
Matthijs J.D. Baars
ADAntonella F.M. Dost
Antonella F.M. Dost
MTMarvin E. Tanenbaum
Marvin E. Tanenbaum
Cell-to-cell heterogeneity is a common feature of viral infection that can generate enormous complexity, complicating understanding of infection progression and interpretation of differences between viral variants. To overcome these challenges, we developed a technology to visualize the infection cycle of human influenza A virus (IAV) from start-to-finish in individual living cells with unprecedented spatial and temporal resolution, which identified numerous distinct pathways through which infection can progress. We show that heterogeneous viral gene expression drives infection cycle heterogeneity, and identified genome packaging, vRNP transcriptional activation and host cell division as major determinants of gene expression variability. Our work maps out the complete IAV infection cycle, identifies the origin of infection heterogeneity and provides a broadly-applicable technology for studying IAV and other viruses.